Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial.
about
Probiotics and Time to Achieve Full Enteral Feeding in Human Milk-Fed and Formula-Fed Preterm Infants: Systematic Review and Meta-AnalysisNovel perspectives on therapeutic modulation of the gut microbiotaChallenges of infant nutrition research: a commentaryWhat Evidence Underlies Clinical Practice in Paediatric Surgery? A Systematic Review Assessing Choice of Study DesignThe Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of ChildhoodPrevention and treatment of neonatal nosocomial infections.Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding Trials.The Microbiome of Infants Recruited to a Randomised Placebo-controlled Probiotic Trial (PiPS Trial)Transitioning From Descriptive to Mechanistic Understanding of the Microbiome: The Need for a Prospective Longitudinal Approach to Predicting DiseaseLongitudinal development of the gut microbiome and metabolome in preterm neonates with late onset sepsis and healthy controls.Lactobacillus acidophilus/Bifidobacterium infantis probiotics are associated with increased growth of VLBWI among those exposed to antibiotics.Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature InfantBenefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates - A Retrospective Cohort StudyTemporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and diseaseA methodological framework for assessing agreement between cost-effectiveness outcomes estimated using alternative sources of data on treatment costs and effects for trial-based economic evaluations.The "Golden Age" of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants.Probiotics and mastitis: evidence-based marketing?Necrotising enterocolitis and mortality in preterm infants after introduction of probiotics: a quasi-experimental studyPrevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis.Probiotics Prevent Late-Onset Sepsis in Human Milk-Fed, Very Low Birth Weight Preterm Infants: Systematic Review and Meta-Analysis.Bifidobacterium breve M-16V as a Probiotic for Preterm Infants: A Strain-Specific Systematic Review.Patterns of Early-Life Gut Microbial Colonization during Human Immune Development: An Ecological PerspectiveeNewborn: The Information Technology Revolution and Challenges for Neonatal Networks.Dysbiosis in the intensive care unit: Microbiome science coming to the bedside.Impact of probiotics on necrotizing enterocolitis.Microbial therapeutic interventions.Necrotizing enterocolitis and preterm infant gut bacteria.Survey and evidence based review of probiotics used in very low birth weight preterm infants within the United States.Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing Enterocolitis.Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: An updated meta-analysis.Impact of Antibiotics on Necrotizing Enterocolitis and Antibiotic-Associated Diarrhea.Probiotics for the prevention of necrotising enterocolitis in very low-birth-weight infants: a meta-analysis and systematic review.Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study.Ghost probiotics with a combined regimen: a novel therapeutic approach against the Zika virus, an emerging world threat.A randomized synbiotic trial to prevent sepsis among infants in rural India.Nutritional strategies and gut microbiota composition as risk factors for necrotizing enterocolitis in very-preterm infants.ESBL-producing Enterobacteriaceae in 24 neonatal units and associated networks in the south of England: no clustering of ESBL-producing Escherichia coli in units or networks.Probiotics and Innate and Adaptive Immune Responses in Premature Infants.Probiotic supplementation in preterm infants does not affect the risk of retinopathy of prematurity: a meta-analysis of randomized controlled trials.The Hidden Treasure of Neonatal Screening: Identifying New Risk Factors and Possible Mechanisms of Necrotizing Enterocolitis Through Big Data.
P2860
Q26739951-594B1EE5-70E6-45DD-8299-458CAE5638BDQ26745706-D4627AA4-AC41-431D-ABA3-B404DD3D9C16Q26751177-5F3CDA86-64BA-4D0A-9EAB-381E7524B392Q26766697-42135CB6-A541-4493-9974-89E84999828EQ28075770-D3F70ACD-9A56-4497-8930-75E2C1BFED32Q30235610-7DB842A6-F9DC-499D-AF07-0ED7F3BDCC51Q33645689-85CD96EB-6AC8-4EEB-9B1D-B68BED5C525DQ33817825-C084C768-7E91-4528-95E7-740C7E3B5AA5Q33822244-69FF1341-0F64-46E7-9441-CBEBE6F65418Q33901540-0E190708-D80D-4485-BA43-FF011CB44FB3Q33912012-C1DC2013-4740-447D-AC1E-1A74C1BADCF8Q35922759-8B1056D9-F214-470E-BFCD-49499A456420Q35949040-0BACFC13-CBCC-4EF2-931B-995A8D7A8148Q36235952-2EBC6C4C-6B23-453B-9B1A-8009AE4C48F0Q36274875-506A147B-096B-42B2-B44F-BFDE07987573Q36280217-39DDFF56-37E4-4782-8CCF-FB00C1B60E9CQ37113302-5D158F97-F5DB-40EB-A33B-8A33ADC8720CQ37193195-79B12073-A3EF-4C94-9835-DFDD7D2BFCE6Q37347035-283AD5DB-D151-453E-9305-2E0DC2F10BBFQ38614389-5FAE4188-22D6-474D-BA59-919D3667FC05Q38630332-2226FE7F-5B1C-4FE6-9A97-793FC863AC0EQ38663368-9190E82F-9BA3-4F36-9AFA-CB534A33BD22Q38679826-85E4FFBC-8AA6-47CC-A40B-65DB2FCE423BQ38793203-F7FD8267-41FD-436C-8852-8A85072FEE58Q38796288-1EC85179-5DA3-44E2-9514-0226A2A733F6Q38822502-CA2B5C49-6F0E-4703-97F4-386DD96EB398Q38876651-A4B1A6C1-70F8-4635-A4D8-C163F87A9FD1Q38943477-3E73D4C5-E61D-4660-9270-F0F088F40A6FQ38955406-0C6B7E42-6E76-4746-9098-9FA026BED044Q38969590-A6491338-3F68-4F7F-A7ED-E8F775F1EEFEQ39121926-7DDCDAEC-F50D-415E-8C38-D4FBF15694E4Q39283163-149C3D03-75EC-413E-8B91-11390EB1173DQ39927380-933A79AC-E922-4E39-8A59-3A9207CB287EQ40037758-EF611985-54ED-4B4A-895A-6645104CD77BQ40081393-E00A0097-D10E-43CF-AC4D-4A2D9C22DD17Q40142108-8AA1B540-C2D6-41CE-9C8C-39322B1CCF1EQ40836938-6BB2C41E-69DD-4022-A894-2A0CB4C94C18Q42366144-915BCA41-C44C-4221-AB6B-4883D3BD0F86Q42376142-8115BA4C-416E-4905-AC3D-C07CA1E62BC1Q44353433-9982A913-2C9B-4A0C-8036-B9923F9A9C77
P2860
Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Bifidobacterium breve BBG-001 ...... ised controlled phase 3 trial.
@en
type
label
Bifidobacterium breve BBG-001 ...... ised controlled phase 3 trial.
@en
prefLabel
Bifidobacterium breve BBG-001 ...... ised controlled phase 3 trial.
@en
P2093
P1433
P1476
Bifidobacterium breve BBG-001 ...... ised controlled phase 3 trial.
@en
P2093
Edmund Juszczak
Kate Costeloe
Mark Wilks
Michael R Millar
Pollyanna Hardy
Probiotics in Preterm Infants Study Collaborative Group
P304
P356
10.1016/S0140-6736(15)01027-2
P407
P577
2015-11-25T00:00:00Z